DEPRESSANT, ANTICONVULSANT AND ANTIBACTERIAL ACTIVITIES OF HIPPOCRATEA AFRICANA

10
Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153. ~ 144 ~ e - ISSN - 2249-7722 Print ISSN - 2249-7730 International Journal of Phytotherapy www.phytotherapyjournal.com DEPRESSANT, ANTICONVULSANT AND ANTIBACTERIAL ACTIVITIES OF HIPPOCRATEA AFRICANA *Jude E. Okokon 1 , Koofreh Davies 2 , Bassey S. Antia 3 , Patience J. Okokon 1 1 Department of Pharmacology and Toxicology Faculty of Pharmacy, University of Uyo, Uyo, Nigeria. 2 Department of Physiology, Faculty of Basic Medical Sciences, University of Uyo. 3 Department of Chemistry, Faculty of Sciences, University of Uyo, Uyo, Nigeria. INTRODUCTION Hippocratea africana (Willd.) Loes.ex Engl. (Celastraceae) syn. Loeseneriella africana (Willd.) N.Halléis a green forest perennial climber without hairs (glabrous), reproducing from seeds [1]. It is commonly known as African paddle-pod. The Ibibio tribe of Nigeria calls it „Ebaenangenang‟. The plant is widely distributed in tropical Africa. The root of the plant is used traditionally by the Ibibios of the Niger Delta region of Nigeria in the treatment of various ailments such asfever, convulsion, malaria, body pains, diabetes and diarrhea [2]. Ethnobotanical survey revealed that decoction of the plant‟s root is also use as an antidote or antipoison to treat liver and inflammatory diseases such as jaundice and hepatitis [3-5].The plant (root) has been reported by Okokon et al [2] to possess in vivo anti-plasmodial activity. Other biological activities include; anti- inflammatory and analgesic [6], anti-diarrheal, antiulcer [7], anti-diabetic and hypolipidemic activities Corresponding Author:-Jude E. Okokon Email: [email protected] ABSTRACT Hippocratea africana (Willd.) Loes.ex Engl. (Celastraceae) is used locally to treat convulsion and microbial infections. The root extract of Hippocratea africana was evaluated for depressant effect and antimicrobial activity.Depressant activity was evaluated using open field, force swimming, tail suspension tests and phenobarbitone-induced sleeping time. Anticonvulsant activity was testedagainst pentylenetetrazol and aminophylline-induced convulsions. The root extract/fractions were screened for antimicrobial activity against some typed and pure cultures of bacterial and fungal species using Plate -hole diffusion methodon Mueller Hinton agar (MHA) for bacteria and Sabouraud Dextrose Agar (SDA) for the fungi. Minimum Inhibitory Concentrations (MICs) of active test samples were determined. The root extract decreased significantly (p<0.01) the line crossing, walling and rearing activities in open field test and increased (p<0.001) the immobility time in force swimming and tail suspension tests. The root extract significantly (p<0.001) shortened the onset time of sleep and prolonged the duration of sleep induced by phenobarbitone sodium. The root extract and fractions (200 600 mg/kg) were found to delay significantly (p<0.05 0.001) the onset of tonic/clonic convulsion and prolonged the time of death of the treated mice in PTZ- and aminophylline induced convulsions. The crude extract, chloroform and aqueous fractions were active against Staph aureus, and B. subtilis. P. aeruginosa was sensitive to aqueous fraction only. The extract and fractions were inactive against any fungal isolate. The root extract of H. africana has depressant, anticonvulsant, sedating and antibacterial activities. Key words: Hippocratea africana, Depressant, Anticonvulsant, Antibacterial, Convulsion, Sedation.

description

Hippocratea africana (Willd.) Loes.ex Engl. (Celastraceae) is used locally to treat convulsion and microbial infections. The root extract of Hippocratea africana was evaluated for depressant effect and antimicrobial activity.Depressant activity was evaluated using open field, force swimming, tail suspension tests and phenobarbitone-induced sleeping time. Anticonvulsant activity was testedagainst pentylenetetrazol and aminophylline-induced convulsions. The root extract/fractions were screened for antimicrobial activity against some typed and pure cultures of bacterial and fungal species using Plate -hole diffusion methodon Mueller – Hinton agar (MHA) for bacteria and Sabouraud Dextrose Agar (SDA) for the fungi. Minimum Inhibitory Concentrations (MICs) of active test samples were determined. The root extract decreased significantly (p

Transcript of DEPRESSANT, ANTICONVULSANT AND ANTIBACTERIAL ACTIVITIES OF HIPPOCRATEA AFRICANA

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 144 ~

    e - ISSN - 2249-7722

    Print ISSN - 2249-7730

    International Journal of Phytotherapy

    www.phytotherapyjournal.com

    DEPRESSANT, ANTICONVULSANT AND ANTIBACTERIAL

    ACTIVITIES OF HIPPOCRATEA AFRICANA

    *Jude E. Okokon1, Koofreh Davies

    2, Bassey S. Antia

    3, Patience J. Okokon

    1

    1Department of Pharmacology and Toxicology Faculty of Pharmacy, University of Uyo, Uyo, Nigeria.

    2Department of Physiology, Faculty of Basic Medical Sciences, University of Uyo. 3Department of Chemistry, Faculty of Sciences, University of Uyo, Uyo, Nigeria.

    INTRODUCTION

    Hippocratea africana (Willd.) Loes.ex Engl.

    (Celastraceae) syn. Loeseneriella africana (Willd.)

    N.Hallis a green forest perennial climber without hairs

    (glabrous), reproducing from seeds [1]. It is commonly

    known as African paddle-pod. The Ibibio tribe of Nigeria

    calls it Ebaenangenang. The plant is widely distributed in tropical Africa. The root of the plant is used

    traditionally by the Ibibios of the Niger Delta region of

    Nigeria in the treatment of various ailments such asfever,

    convulsion, malaria, body pains, diabetes and diarrhea

    [2]. Ethnobotanical survey revealed that decoction of the

    plants root is also use as an antidote or antipoison to treat liver and inflammatory diseases such as jaundice and

    hepatitis [3-5].The plant (root) has been reported by

    Okokon et al [2] to possess in vivo anti-plasmodial

    activity. Other biological activities include; anti-

    inflammatory and analgesic [6], anti-diarrheal, antiulcer

    [7], anti-diabetic and hypolipidemic activities

    Corresponding Author:-Jude E. Okokon Email: [email protected]

    ABSTRACT

    Hippocratea africana (Willd.) Loes.ex Engl. (Celastraceae) is used locally to treat convulsion and

    microbial infections. The root extract of Hippocratea africana was evaluated for depressant effect and antimicrobial

    activity.Depressant activity was evaluated using open field, force swimming, tail suspension tests and

    phenobarbitone-induced sleeping time. Anticonvulsant activity was testedagainst pentylenetetrazol and

    aminophylline-induced convulsions. The root extract/fractions were screened for antimicrobial activity against

    some typed and pure cultures of bacterial and fungal species using Plate -hole diffusion methodon Mueller Hinton agar (MHA) for bacteria and Sabouraud Dextrose Agar (SDA) for the fungi. Minimum Inhibitory Concentrations

    (MICs) of active test samples were determined. The root extract decreased significantly (p

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 145 ~

    [8], cytotoxicity against HeLa cells, anti-oxidative burst

    and anti-leishmanial activities [9] and hepatoprotective

    activity [10]. In this study, we report the anticonvulsant

    and antibacterial activities of the root extract of

    Hippocratea africana.

    MATERIALS AND METHODS

    Plant materials

    Fresh roots of H.africana were collected in

    August, 2014 at a forest in Uruan, Akwa Ibom State,

    Nigeria. The plant was identified and authenticated by

    Dr. Margaret Bassey, a taxonomist in the Department of

    Botany, University of Uyo, Uyo. Nigeria. Herbarium

    specimen was deposited atFaculty of Pharmacy

    Herbarium.

    Microorganisms

    Typed and pure cultures of some bacterial and

    fungal species were obtained from Pharmaceutical

    microbiology unit of the Department of Pharmaceutics

    and Pharmaceutical Technology, Faculty of Pharmacy,

    University of Uyo, Uyo and maintained at 40oC on

    nutrient agar plates before use.

    Extraction

    The root materialswere washed and shade-dried

    for two weeks. The dried plants materials were further chopped into small pieces and reduced to powder. The

    powdered material was soaked in 70% ethanol. The liquid

    filtrate was concentrated and evaporated to dryness in

    vacuo 40C using rotary evaporator. The crude ethanolic extract (10 g) was partitioned with a 50:50 mixture of

    distilled water and chloroform. The aqueous fraction was

    evaporated to dryness in a water bath at 60OC and the

    chloroform fraction air-dried. The ethanolic extract, the

    aqueous and chloroform fractions were stored at -4OC

    until used.

    Animals

    The animals (Swiss albino mice of either sex)

    that were used for these experiments were obtained from

    University of Uyo animal house. The animals were

    housed in standard cages and were maintained on a

    standard pelleted feed (Guinea feed) and water ad libitum.

    Permission and approval for animal studies were obtained

    from College of Health Sciences Animal Ethics

    committee, University of Uyo.

    Evaluation of Depressant activity

    Open Field test

    Rats were randomly divided into groups of 5 rats

    each and treated as follows for 5 days before open field

    test; control (normal saline, 2 ml/kg p.o.), imipramine

    (5.0 mg/kg, p.o.) and ethanolic root extract of

    Hippocratea africana (200, 400 and 600 mg/kg, p.o.).

    The open-field arena was made of acrylic (transparent

    walls and black floor, 30 30 15 cm), divided into nine

    squares of equal areas. The open field was used to

    evaluate the exploratory activity of the animal [11]. The

    observed parameters were the number of squares crossed

    (with the four paws) and number of grooming and rearing,

    recorded for 5 min testing period.

    Forced Swimming test

    Mice were randomly divided into groups of 5

    mice each and treated as follows for 5 days before the

    behavioural test; control (normal saline, 2 ml/kg p.o.),

    imipramine (5.0 mg/kg, p.o.) and ethanolic root extract of

    Hippocratea africana (200, 400 and 600 mg/kg, p.o.). For

    assessing antidepressant activities, we employed the

    method described by Porsolt et al [12,13]. The

    development of immobility when mice were placed inside

    an inescapable cylinder filled with water reflects the

    cessation of persistent escape-directed behavior. Briefly,

    mice were individually placed in a circular tank (46 cm

    tall 20 cm in diameter) filled with tap water (25 1C)

    to a depth of 20 cm and left there for 5 min. During this

    period, the behavior of the animals was recorded by an

    observer. Mice were considered immobile when remained

    floating without struggling and making only slight

    movements necessary to maintain the head above the

    water.

    Tail Suspension test (TST)

    Mice of either sex were randomly divided into

    groups of 5 mice each and treated as follows for 5 days

    before open field test; control (normal saline, 2 ml/kg

    p.o.), imipramine (5.0 mg/kg, p.o.) and ethanolic root

    extract of Hippocratea africana (200, 400 and 600 mg/kg,

    p.o.). The total duration of immobility induced by tail

    suspension was measured according to the methods

    described by Steru et al [14]. Briefly, mice both

    acoustically and visually isolated were suspended 50 cm

    above the floor by adhesive tape placed approximately

    1 cm from the tip of the tail. Immobility time was

    recorded during a 6 min period. Mice were considered

    immobile only when they hung passively and were

    motionless.

    Anticonvulsant activity

    Pentylenetetrazol induced Convulsion

    Anticonvulsant effect of the extract was assessed

    using a modified method of Vellucci and Webster [15] on

    overnight fasted mice. The mice were divided into seven

    groups of six animals each and treated with 200, 400 and

    600 mg/kg of the root extract, 400 mg/kg of chloroform

    and aqueous respectively, phenytoin, 40 mg/kg one hour

    before induction of convulsion. Seizure was induced in

    each set of mice with PTZ (70 mg/kg i.p). Control group

    received normal saline. The onset of Clonic/tonic

    convulsion and the mortality rate was recorded and

    compared with the respective control group. The ability of

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 146 ~

    the plant extract to prevent or delay the onset of the hind

    limb extension exhibited by the animals was taken as an

    indication of anticonvulsant activity [16].

    Aminophylline-induced Convulsion

    The extract and fractions were evaluated for

    aminophylline induced convulsion using the method of Juliet et al [17].The mice were divided into seven groups

    of six animals each and treated with 200, 400 and 600

    mg/kg of the extract 400 mg/kg of chloroform and

    aqueous respectively, phenytoin, 40 mg/kg one hour

    before induction of convulsion. Seizure was induced

    using aminophylline (280 mg/kg,i.p). The animals were

    observed for 120 mins after the administration of AMPH

    and the following parameters were noted:

    1. Time to onset of myoclonic jerks in mins. 2. Time to onset of tonic convulsions in mins. 3. Time to death during experimental time of 120 mins. 4. Number of mice dead/alive at 24 hours.

    Effect on phenobarbitone induced sleeping time of rats

    The crude ethanolic extract was evaluated for

    effect on phenobarbitone sodium sleeping time of rats.

    The rats were divided into five groups of five rats each

    (n=5). The extract (200, 400 and 600 mg/kg) was

    administered to various groups of rats, diazepam (2

    mg/kg) was given to the reference group and the control

    group was given distilled water (10 ml/kg). After 30 min

    the groups were treated with phenobarbitone sodium (40

    mg/kg,i.p). The onset and the duration of sleep were noted

    and recorded in minutes.

    Evaluation of antibacterial and antifungal activities of

    the extract

    Plate-hole diffusion test

    The evaluation of antimicrobial activity of the

    extract/fractions were carried out by the Plate -hole

    diffusion method [18] on Mueller Hinton agar (MHA) for bacteria and Sabouraud Dextrose Agar (SDA) for the

    fungi. Solutions of the extract and fractions were prepared

    in 10% Tween 80 to concentrations of 100, 50, 25 and

    12.5mg/ml.

    The innocula of the microorganisms were

    prepared separately from 12h broth cultures (Mueller-

    Hinton broth for bacteria and the Sabouraud dextrose

    broth for the fungi) and incubated at 37C. All culture

    media and distilled water were sterilized at 121C for 15 min in an autoclave. These innocula were diluted with

    sterilized distilled water to obtain a density corresponding

    approximately to 0.5 of McFarland standard turbidity

    scale (108 colony forming unit CFU per ml for the

    bacteria and 103 spores per ml for fungi)[18]. 0.5 ml of

    each innoculum was introduced into the corresponding

    fluid agar medium homogenized and 25 ml of it poured

    into sterile plastic petridishes. The petridishes were

    allowed on the flat slab top for the medium to solidify

    within 30 min. A standard cork borer of 5mm in diameter

    was used to cut four equidistant uniform wells per plate

    on the surface of different plates into which was added

    50l solution of each extract/fraction at varying concentration 12.5, 25, 50 and 100 mg/ml. The reference

    drugs were Gentamicin, batch 20070402 (0.4 mg/ml) and

    Nystatin batch 04D05 (500 g/ml). The plates were

    incubated at 37C for 24 and 48h for the bacteria and fungi respectively. The antimicrobial activity was

    evaluated by measuring the zone of inhibition around the

    hole. Each test concentration had three replications. The

    results were recorded as the mean diameter of the zones

    of growth inhibition surrounding the discs [19].

    Determination of minimum inhibitory concentrations

    (MIC) using macrodilution method

    The Minimum Inhibitory Concentrations (MICs)

    of test samples found to be active by the diffusion test

    were determined based on the macrodilution method [18]

    with some modifications as follows. The test

    extract/fractions were dissolved in 10% Tween 80 to give

    a stock concentration of 100mg/ml and serially diluted

    (two-fold) in a seres of test tubes to a working

    concentration ranging from 1.560 to 100mg/ml using

    nutrient broth supplemented with 10% glucose and 0.05%

    phenol red (colour indicator). These were later inoculated

    with 0.2ml suspension of the test organisms. Microbial

    growth was determined by observing for color change in

    the tube (red to yellow when there is growth). The lowest

    concentration that showed no change of color was

    considered as the MIC.

    Statistical Analysis and Data Evaluation

    Data obtained from this work were analyzed

    statistically using one way ANOVA followed by a post

    test (Turkey-Kramer multiple comparison test).

    Differences between means was considered significant at

    1% and 5% level of significance, that is P 0.01and 0.05

    RESULTS

    Open field test

    Administration of root extract of H. africana

    (200 600 mg/kg) for 5 days caused significant (p

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 147 ~

    no effect on the locomotor activity of the rats. The

    standard drug, imipramine (5 mg/kg), produced a

    significant (p

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 148 ~

    Table 2. Anticonvulsant Activity of Hippocratea africana root extract on PTZ- induced convulsion

    Data are represented as mean SEM .significant at aP < 0.05;bp

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 149 ~

    Table 5. Minimum inhibitory concentration of ethanolic crude root extract and fractions of H. africana (mg/ml).

    Organism Crude Extract/ Fraction

    Ethanolic Crude Extract Aqueous Chloroform

    Staph. aureus NCTC 6571 10 6.5 3.125

    Bacillus subtilis NCTC 8853 30 7.0 3.125

    Pseudomonas aureginosa ATCC 27853 - 30 -

    Figure 1. Bar diagram showing the effect of Hippocratea

    africana root extract on line crossing frequency of rat

    Results are represented as mean SEM with n = 5 in each group. *p

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 150 ~

    Effect of the crude extract and fractions of H. Africana

    on some microorganisms

    Table 4 shows the diameters of the zones of

    inhibition exhibited by ethanolic crude extract and

    fractions at various concentrations employed. The crude

    extract, chloroform and aqueous fractions showed a

    narrow spectrum of activity against gram positive Staph

    aureus (NCTC 6571) and Bacillus subtilis (NCTC 8853).

    Pseudomonas aeroginosa (ATCC 27853) was the only

    gram negative bacteria tested that was sensitive to the

    aqueous fraction. The chloroform fraction had the highest

    activity against both Staph aureus and Bacillus subtilis

    followed by aqueous fraction and the crude extract. Other

    tested organisms were not sensitive to either the crude

    extract or fractions..The activities of the crude

    extract/fractions were not comparable to that of the

    standard, streptomycin. The crude extract and the

    fractions were inactive against all fungal species tested.

    The results of minimum inhibitory concentrations

    (MIC)of the crude / fraction are shown in Table 5. The

    lowest MICs of chloroform fraction (3.125 mg/ml) were

    recorded against B.subtilis (NCTC 8853) and Staph.

    Aureus (NCTC 6571). While the MICs of aqueous

    fraction against B. subtilis and Staph aureus were 7.0 and

    6.5 mg/ml respectively. Aqueous fraction also inhibited P.

    aeruginosa with MIC value of 30.0 mg/ml.

    DISCUSSION

    In this study, evaluation of the effect of ethanolic

    root extract on central nervous system was carried out in

    rats using different models; Open field test, tail

    suspension test and force swimming test. The root extract

    (200 600 mg/kg) was found to cause significant dose dependent reductions in the frequency of line crossing and

    rearing activities of the pretreated rats, while the walling

    frequency was significantly (p

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 151 ~

    delay the onset of tonic/clonic convulsions and prolonged

    the time of the death of the treated mice against

    pentylenetetrazol and aminophylline induced convulsions.

    The aqueous fraction was observed to have the highest

    activity.

    The exact mechanisms of seizures induced by

    aminophylline appear to be diverse, multiple and

    complex, and also unclear. Evidence suggests that

    seizures induced by aminophylline, could be the result of

    adenosine receptor antagonism or due to inhibition of

    cerebral nucleotidase activity [30, 31], which lower the

    adenosine content in the brain and eventually lead to a

    process of disinhibition. However, report has it that di-

    phenylhydantoin a potent inhibitor of adenosine uptake

    was ineffective in preventing these seizures [32]. Apart

    from non-specific adenosine receptor antagonism [33],

    aminophylline is thought to have inhibitory influence on

    adenosine synthesis. At higher doses inhibition of

    phosphodiesterase activity including mobilization of

    intracellular calcium ions from labile stores are said to be

    implicated in AMPH-induced seizures [34, 35]. However,

    a report by Ray et al., [36], has implicated oxidative stress

    due to the generation of free radicals and reactive oxygen

    species to be responsible for the seizures induced by

    aminophylline.

    Hippocratea africana root extract and fraction

    which was observed to delay the onset of aminophylline

    induced convulsion, has been reported to contain -thujene , sabinene and sesquiterpenes, which have been

    implicated in the anticonvulsant activities of plants

    [37,38]. These compounds may be responsible for the

    observed anticonvulsant activity of the plant. Also,

    Okokon et al. [10] reported the antioxidative property of

    the root extract. The antioxidant activity of this root

    extract may be responsible for the observed protection

    against aminophylline induced convulsion.

    According to De Sarro et al.,[39],

    pentylenetetrazol (PTZ)is suggested to exert its

    anticonvulsant effect by inhibiting the activity of gamma

    aminobutyric acid (GABA) at GABAA receptors. Gamma

    aminobutyric acid is the major inhibitory neurotransmitter

    which is implicated in epilepsy. The enhancement and

    inhibition of the neurotransmission of GABA will

    attenuate and enhance convulsion respectively [40,41].

    Phenobarbitone and diazepam, standard epileptic

    drugs,have been shown to exert their antiepileptic effects

    by enhancing GABA-mediated inhibition in the brain

    [42,43]. These drugs are reported to antagonise PTZ-

    induced convulsion [44] by enhancing GABA

    neurotransmission. Phenytoin was unable to prevent PTZ-

    induced seizure because it is thought to exert its

    antiepileptic effect by blocking sodium ions into brain

    cells thus inhibiting generation of repitative action

    potential [42]. Since the root extract and fractions of

    Hippocratea africana were able to delay PTZ induced convulsion it is probable that they may be interfering with

    gabaergic mechanism(s) to exert its effect. Their

    anticonvulsant activities are due to their phytochemical

    components as reported above.

    The ethanol root extract of H. africana was

    found to significantly enhanced duration of the

    phenobarbitone sodium -induced hypnotic effect, which

    was observed in the shortening of time of onset of sleep

    and prolonging the duration of sleep following its

    administration suggesting a depressant activity on the

    CNS. Substances which possess CNS depressant activity

    either decrease the time for onset of sleep or prolong the

    duration of sleep or both [45, 46]. A prolongation of the

    phenobarbitone effect could involve a facilitation of

    GABA mediated postsynaptic inhibition through

    allosteric modification of GABAA receptors.

    The root extract and fractions were found to

    exert antibacterial activity against Gram positive S.

    aureus and B. subtilis as well as Gram negative P.

    aureginosa. This activity may have resulted from the

    presence of phytochemical compounds such as

    monoterpenes (thujene and sabinene) and sesquiterpenes

    as reported above.

    Compounds such as terpenes (mono and

    sesquiterpenes) which have been implicated in

    antibacterial activities of plants [47, 48] have been found

    to be present in this extract. These compounds may have

    been responsible for the antibacterial activity observed in

    this study.

    CONCLUSION

    From the results of this study, the root extract/

    fractions possess significant CNS depressant and

    anticonvulsant activities as well as a considerable

    antibacterial activity. It will be interesting to isolate and

    characterised the active ingredient in this extract

    CONFLICT OF INTEREST There is no conflict of interest.

    ACKNOWLEDGEMENT The authors are grateful to Mr. Nsikan Malachy

    Udo of Department of Pharmacology and Toxicology for

    technical assistance.

    REFERENCES

    1. Dalziel JM. Useful Plants of West Tropical Africa, Crown Agents for Overseas Government, London, 1956. 2. Okokon JE, Ita BN, Udokpoh AE.The in vivo antimalarial activities of Uvaria echamae and Hippocratea africana.

    Ann Trop Med Parasitol. 100, 2006, 585 - 590.

    3. Etukudo I. Forests, Our Divine Treasure. Dorand Publishers, Nigeria,2000, 156 - 180.

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 152 ~

    4. Etukudo I. Ethnobotany, Conventional and Traditional Uses of Plants. The Verdict Press, Nigeria, 2003, 83 134. 5. Ajibesin KK, EkpoBA, Bala DN, Essien EE, Adesanya SA. Ethnobotanical survey of Akwa Ibom State of Nigeria.

    J Ethnopharmacol,115, 2008, 387 408. 6. Okokon JE, Antia BS, Umoh EE.Analgesic and anti-inflammatory activities of Hippocratea africana.Int J Pharmacol, 4,

    2008,51 55. 7. Okokon JE, Akpan HD, Ekaidem I, Umoh EE. Antiulcer and antidiarrhoealactivities of Hippocratea africana.Pak J

    Pharmaceut Sci, 24, 2011, 201205. 8. Okokon JE,Antia BS,Umoh EE, Etim EI.Antidiabetic and hypolipidaemic activities of Hippocratea africana.Int. Journal

    of Drug Devand Res, 2, 2010, 501 -506.

    9. Okokon JE, Dar A, Choudhary MI. Cellular Antioxidant, Cytotoxic and Antileishmanial activities of Hippocratea africana. J Nat Pharmaceuticals, 4(2), 2013, 81 85.

    10. Okokon JE, Nwafor PA, Ukeme C. Choudhary MI, Dar A. Antioxidative burst and hepatoprotective effects ofethanol root extract of Hippocratea africana against Paracetamol-induced liver injury. Pharmaceutical Biology, 51(7), 2013, 872

    - 880.

    11. Archer J. Tests for emotionality in mices and mice, a review. Anim Behav, 21, 1973, 205 - 235. 12. Porsolt RD, Bertin A, Jalfre M. Behavioural despair in mice, a primary screening test for antidepressants. Archives

    Internationales de Pharmacodynamieet de Therapie, 229, 1977, 327 - 336.

    13. Porsolt RD, Anton G, Deniel M, Jalfre M. Behavioural despair in rats, a new model sensitive to antidepressant treatments. Eur J Pharmacol, 47, 1978, 379 - 391.

    14. Steru L, Chermat R, Thierry B, Simon P.The tail suspension test, a new method for screening antidepressants in mice. Psychopharmacology, 85, 1985, 367 - 370.

    15. Vellucci SV and Webster RA.Antagonism of caffeine-induced seizures in mice by Ro. 15-1788. European Journal of Pharmacology, 97, 1984, 289-293.

    16. Amabeoku GJ, Chikuni O. Cimetidine induced seizures in mice, antagonism by some gabaergicagents. Biochem Pharmacol, 46, 1993, 2171 - 2175.

    17. Juliet J, Subramanyam K, SureshS. Individual and combined effects of N6-cyclopentyladenosine, flunarizine and diazepam on aminophylline induced recurrent generalized seizures in mice. Polish J Pharmacol, 55, 2003, 559 - 564.

    18. Berghe VA, Vlietinek AJ. Screening methods for anti-bacterial and antiviral agents from higher plants. Methods for Plant Biochem, 6, 1991,47 - 68.

    19. Lyudmila B, Sirigan D, Radka K, Nikolai K, Galina G, Ivan M, Rossen N and Zacharii K. Inhibition of Helicobacter pylori growth in vitro by Bulgarian propolis preliminary report. J Med Microb, 52, 2003,417-419.

    20. Ozturk Y, Aydini S, Beis R, Baser KHC, Berberoglu H. Effect of Hypericum pericum L. and Hypericum calycinum l. extracts on the central nervous system in mice, Phytomedicine, 3(2), 1996, 139 - 146.

    21. Kolawole OT, Makinde JM, Olajide OA. Central nervous system depressant activity of Russeliae quisetiformis. Nig J Physiol Sci, 22(1-2), 2007, 59-63.

    22. Yadav AV, Kawale LA, Nade VS. Effect of Morus alba L leaves on anxiety in mice. Ind J Pharmacol,40(1),2008,32-36. 23. Hemby SE, Lucki I, Gatto G, Singh A, Thornley C, Matasi J. Potential antidepressant effects of novel tropane

    compounds, selective for serotonin and dopamine transporters. J Pharmacol Experimental Therapeutics, 282,1997, 727 -

    733.

    24. Dhingra D, Sharma A. Evaluation of antidepressant-like activity of glycyrrhizin in mice. Ind J Pharmacol, 37(6), 2005, 390-394.

    25. Lucki, I. The forced swimming test as a model for core and component behavioural effects of antidepressant drugs. BehaviouralPharmacol, 8, 1997, 523 - 532.

    26. Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology, 121, 1995, 6672.

    27. Willner P. The validity of animal models of depression. Psychopharmacology, 83,1984, 116. 28. Hossain MM, Biva IJ, Jahangir R, Vhuiyan MMI. CNS depressant and analgesic activity of Aphanamixis polystachya

    (wall.) parker leaf extract in mice. Afr J Pharm Pharmacol, 3(5), 2009, 282 - 286.

    29. Noldner M, Schotz K. Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Medica, 68, 2002, 577 - 580.

    30. Chu NS. Caffeine and aminophylline-induced seizures, Epilepsia, 22, 1981, 85 -95. 31. Jensen MH, Jorgensen S, Nielsen H, et al. Is theophylline-induced seizure in man caused by inhibition of cerebral -

    nucleotidase activity. Acta of Pharmacology and Toxicology, 55, 1984, 331-334.

    32. Sharma A, Sandhir R. Oxidative stress after lithium-pilocarpine induced status epilepticus in mice brain. Annals of Neurosciences, 13(1), 2006,1 - 4.

  • Inter. J. of Phytotherapy / Vol 4 / Issue 3 / 2014 / 144-153.

    ~ 153 ~

    33. Daval J, Nehlig A, Nicholas F. Physiological & Pharmacological properties of adenosine, Therapeutic implications. Life Sciences, 49, 1991, 1435 - 53.

    34. Neering IR, Me Burney RM. Role for microsomal calcium storage in mam-malian neurons? Nature (London), 309, 1984, 158 -160.

    35. Tutka P, Turski WA, Kleinrok Z. Influence of aminophylline and strychnine on the protective activity of excitatory amino acid antagonists against maximal electroshock-induced convulsions in mice. Journal of Neural Transmission,

    103, 1996, 307-314.

    36. Ray A, Gulati K, Anand S, Vijayan V. Pharmacological studies on mechanisms of aminophylline induced seizures in rats. Ind J ExplBiol, 43, 2005, 849-853.

    37. Sayyah M, Kamalinejad M, Hidage RB, Rustaiyan, A. Antiepileptic potential and composition of the fruit essential oil of Ferula gummosaboiss. Iran Biomed, J, 5, 2001, 69-72.

    38. Almeida R N, Agra M F,Maior FN, de Sousa D. P. Essential Oils and Their Constituents, Anticonvulsant Activity. Molecules, 16, 2011, 2726 -2742.

    39. De Sarro A, Cecchetti V, Fravlini V, Naccari F, Tabararrini O, De Sarro G. Effect of novel 6- desfluoroquinolones and classic quinolones on pentylene tetrazole induced seizures in mice. Antimicrob Agents Chemother, 43,1999, 1729 1736.

    40. GaleK.(1992).GABA and epilepsy, Basic concepts from preclinical research.Epilepsia, 33,1992, S3 S12. 41. WestmorelandBF,BenarrochEE,DubeJR,ReganTJ,Sandok BA. Medical Neurosciences.Mayo Foundation ,Rochester.

    1994, 307 312. 42. Porter RJ, Meldrum BS. Antiseizure drugs. In, Katzung BG. (Ed), Basic and Clinical Pharmacology. 8th ed. Lange

    Medical Books/McGraw-hill, New York,2001, 403 417. 43. Rang HP, Dale MM, Ritter JM, Moore P K. Pharmacology, 5th ed.Churchill Livingstone. Edinburg, 2003, 557 - 587. 44. Amabeoku GJ, Green I, Kabatende J. Anticonvulsant activity of Cotyledon orbiculata L. (Crassulaceae) leaf extract in

    mice. Journal of Ethnopharmacology, 112, 2007, 101107. 45. Nyeem MAB, Alam MA, Awal MA, Mostofa M, Uddin SJ, Islam N, Rouf R. CNS depressant effect of the crude

    ethanolic extract of the flowering tops of Rosa damascena. Iranian J Pharmacol Ther, 5, 2006, 171-174.

    46. RaquibulHasan SM, Hossain MM, Akter R, Jamila M, Mazumder EHM, Rahman S. Sedative and anxiolytic effects of different fractions of the Commelina benghalensis Linn. Drug Discov Ther, 3, 2009,221- 227.

    47. Habtemariam S, Gray AI, Waterman PG. A new antibacterial sesquiterpenes from Premna aligotricha. J Nat Prod, 56, 1993, 3864 - 74.

    48. Uma B, Parvathavarthini R. Antibacterial Effect of Hexane Extract of Sea Urchin, Temnopleurus alexandri. Inter JPharmTechRes, 2, 2010, 1677 - 1680.